Investigational and Therapeutic Drugs
Paul M. Shore, MD, MS
Director, Clinical Program Leader, Clinical Development, Hematology
CSL Behring
Drexel University College of Medicine
King of Prussia, Pennsylvania, United States
Bart J. Biemond, MD, PhD
Head of Hemoglobinopathy Center
Amsterdam UMC, University of Amsterdam
Amsterdam, Noord-Holland, Netherlands
Rachel Kesse-Adu, MBBCh
Consultant Haematologist
Guy's and St Thomas Hospital, England, United Kingdom
Ezanul Wahab, MBBCh MRCP(UK) DPM MFPM
Director Early Phase Research
MAC Clinical Research, England, United Kingdom
Payal C. Desai, MD (she/her/hers)
Clinical Associate Professor, Hematology and Oncology
Wake Forest University School of Medicine
Levine Cancer Institute
Charlotte, North Carolina, United States
Alex Boucher, MD (he/him/his)
Associate Professor
University of Minnisota
University of Minnesota
Minneapolis , Minnesota, United States
Perla Eleftheriou, MD, MRCP, FRCPath
Consultant Haematologist
University College London Hospital, England, United Kingdom
Anita Rijneveld, MD
Hematologist
Erasmus University, Zuid-Holland, Netherlands
Laura M. De Castro, MD
Director of Benign Hematology
University of Pittsburgh Medical Center
University of Pittsburgh
Piitsburgh, Pennsylvania, United States
Shayla Bergmann, MD
Director of Pediatric Nonmalignant Hematology
Medical University of South Carolina, South Carolina, United States
Gregory J. Kato, MD (he/him/his)
Global Product Lead
CSL
University of Pittsburgh School of Medicine
King of Prussia, Pennsylvania, United States
Jeanine Jochems, PhD
Clinical Pharmacologist
CSL Behring
King of Prussia, Pennsylvania, United States
Francine Wilson, PhD
Senior Clinical Scientist
CSL Behring
King of Prussa, Pennsylvania, United States
Kerstin Jung, n/a
Senior Global Trial Leader
CSL Behring, Hessen, Germany
Victor R. Gordeuk, MD
Professor of Medicine
University of Illinois at Chicago
Chicago, Illinois, United States